July 31, 2019
In re: Sensipar (Cinacalcet Hydrochloride Tablets) Antitrust Litigation
Case Number:
1:19-md-02895
Court:
Nature of Suit:
Multi Party Litigation:
Multi-district Litigation, Class Action
Judge:
Firms
- Bifferato Firm
- Chimicles Schwartz
- Farnan LLP
- Gibson Dunn
- Hughes Hubbard
- Labaton Keller
- Lite DePalma
- Morris Nichols
- NastLaw
- Rivero Mestre
- Shaw Keller
Companies
- Allergan PLC
- Amgen Inc.
- Cipla Ltd.
- LifeWallet
- Teva Pharmaceutical Industries Ltd.
- United Food & Commercial Workers International Union
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
January 10, 2024
Union Funds Exit Amgen, Teva Antitrust MDL
Teva Pharmaceuticals has settled its differences with the union funds making up the indirect purchase class in multidistrict litigation accusing it of hatching an illegal deal to remove a generic calcium-control drug from the market.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login